Patents by Inventor Swetha Murali

Swetha Murali has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detection of nucleic acid and non-nucleic acid target molecules
    Patent number: 11965205
    Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more non-nucleic acid targets of interest in a sample. The compositions and methods provide signal boost upon detection of non-nucleic acid targets of interest in less than one minute and in some instances instantaneously at ambient temperatures down to 25° C. or less, allow for massive multiplexing, high accuracy, minimal non-specific signal generation, and are easily reprogrammable.
    Type: Grant
    Filed: October 5, 2023
    Date of Patent: April 23, 2024
    Assignee: VedaBio, Inc.
    Inventors: Swetha Murali, Anurup Ganguli, Ketki Sawant, Ravi Vijayendran
  • DETECTION OF NUCLEIC ACID AND NON-NUCLEIC ACID TARGET MOLECULES
    Publication number: 20240124919
    Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more non-nucleic acid targets of interest in a sample. The compositions and methods provide signal boost upon detection of non-nucleic acid targets of interest in less than one minute and in some instances instantaneously at ambient temperatures down to 25° C. or less, allow for massive multiplexing, high accuracy, minimal non-specific signal generation, and are easily reprogrammable.
    Type: Application
    Filed: October 5, 2023
    Publication date: April 18, 2024
    Inventors: Swetha Murali, Anurup Ganguli, Ketki Sawant, Ravi Vijayendran
  • DELIVERY OF THERAPEUTICS IN VIVO VIA A CRISPR-BASED CASCADE SYSTEM
    Publication number: 20240110164
    Abstract: The present disclosure relates to compositions of matter and methods used to activate effector nucleic acids and effector targets in vivo via a CRISPR-based cascade system. The compositions and methods achieve non-specific delivery of cascade system components to cells yet the cascade system works in a cell-specific manner.
    Type: Application
    Filed: September 29, 2023
    Publication date: April 4, 2024
    Inventors: Anurup Ganguli, Joshua Miller, Andrew Garst, Robert Plasschaert, Swetha Murali